# Quaker Chemical Corp: financial statements, quarterly

KWR · NYSE · CIK 81362 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kwr.md) · [Financials](/companies/kwr/financials.md) · [Filings](/companies/kwr/filings.md) · [Insiders](/companies/kwr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kwr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [467 d](/filings/0001628280-26-010694.md) | [470](/filings/0000081362-25-000059.md) | [464](/filings/0000081362-25-000120.md) | [462](/filings/0001628280-25-047572.md) | [444 d](/filings/0001628280-26-010694.md) | [443](/filings/0001628280-26-028949.md) | [483](/filings/0001628280-26-051107.md) | [494](/filings/0001628280-26-068284.md) | [468 d](/filings/0001628280-26-010694.md) | [480](/filings/0001628280-26-028949.md) | [533](/filings/0001628280-26-051107.md) | [545](/filings/0001628280-26-068284.md) |
| Cost of revenue | $m | [296 d](/filings/0001628280-26-010694.md) | [288](/filings/0000081362-25-000059.md) | [288](/filings/0000081362-25-000120.md) | [290](/filings/0001628280-25-047572.md) | [288 d](/filings/0001628280-26-010694.md) | [282](/filings/0001628280-26-028949.md) | [312](/filings/0001628280-26-051107.md) | [313](/filings/0001628280-26-068284.md) | [303 d](/filings/0001628280-26-010694.md) | [304](/filings/0001628280-26-028949.md) | [343](/filings/0001628280-26-051107.md) | [351](/filings/0001628280-26-068284.md) |
| Gross profit | $m | [171 d](/filings/0001628280-26-010694.md) | [182](/filings/0000081362-25-000059.md) | [176](/filings/0000081362-25-000120.md) | [173](/filings/0001628280-25-047572.md) | [156 d](/filings/0001628280-26-010694.md) | [161](/filings/0001628280-26-028949.md) | [172](/filings/0001628280-26-051107.md) | [181](/filings/0001628280-26-068284.md) | [166 d](/filings/0001628280-26-010694.md) | [177](/filings/0001628280-26-028949.md) | [189](/filings/0001628280-26-051107.md) | [194](/filings/0001628280-26-068284.md) |
| Selling, general and administrative | $m | [121 d](/filings/0001628280-26-010694.md) | [124](/filings/0000081362-25-000059.md) | [117](/filings/0000081362-25-000120.md) | [118](/filings/0001628280-25-047572.md) | [125 d](/filings/0001628280-26-010694.md) | [119](/filings/0001628280-26-028949.md) | [127](/filings/0001628280-26-051107.md) | [126](/filings/0001628280-26-068284.md) | [130 d](/filings/0001628280-26-010694.md) | [136](/filings/0001628280-26-028949.md) | [140](/filings/0001628280-26-051107.md) | [136](/filings/0001628280-26-068284.md) |
| Operating income | $m | [48.3 d](/filings/0001628280-26-010694.md) | [55.5](/filings/0000081362-25-000059.md) | [58.4](/filings/0000081362-25-000120.md) | [51.7](/filings/0001628280-25-047572.md) | [29.0 d](/filings/0001628280-26-010694.md) | [27.6](/filings/0001628280-26-028949.md) | [(52.5)](/filings/0001628280-26-051107.md) | [46.6](/filings/0001628280-26-068284.md) | [31.2 d](/filings/0001628280-26-010694.md) | [33.6](/filings/0001628280-26-028949.md) | [40.6](/filings/0001628280-26-051107.md) | [48.9](/filings/0001628280-26-068284.md) |
| Interest expense | $m | not reported | [10.8](/filings/0000081362-25-000059.md) | [10.8](/filings/0000081362-25-000120.md) | [10.3](/filings/0001628280-25-047572.md) | [9.1 d](/filings/0001628280-26-010694.md) | [9.5](/filings/0001628280-26-028949.md) | [12.8](/filings/0001628280-26-051107.md) | [10.9](/filings/0001628280-26-068284.md) | [10.8 d](/filings/0001628280-26-010694.md) | [9.9](/filings/0001628280-26-028949.md) | [9.9](/filings/0001628280-26-051107.md) | [10.0](/filings/0001628280-26-068284.md) |
| Income tax | $m | [18.6 d](/filings/0001628280-26-010694.md) | [12.5](/filings/0000081362-25-000059.md) | [15.8](/filings/0000081362-25-000120.md) | [12.2](/filings/0001628280-25-047572.md) | [8.8 d](/filings/0001628280-26-010694.md) | [7.5](/filings/0001628280-26-028949.md) | [5.5](/filings/0001628280-26-051107.md) | [9.3](/filings/0001628280-26-068284.md) | [2.3 d](/filings/0001628280-26-010694.md) | [7.1](/filings/0001628280-26-028949.md) | [11.2](/filings/0001628280-26-051107.md) | [11.8](/filings/0001628280-26-068284.md) |
| Net income | $m | [20.2 d](/filings/0001628280-26-010694.md) | [35.2](/filings/0000081362-25-000059.md) | [34.9](/filings/0000081362-25-000120.md) | [32.3](/filings/0001628280-25-047572.md) | [14.2 d](/filings/0001628280-26-010694.md) | [12.9](/filings/0001628280-26-028949.md) | [(66.6)](/filings/0001628280-26-051107.md) | [30.5](/filings/0001628280-26-068284.md) | [20.7 d](/filings/0001628280-26-010694.md) | [19.7](/filings/0001628280-26-028949.md) | [26.8](/filings/0001628280-26-051107.md) | [30.0](/filings/0001628280-26-068284.md) |
| Diluted EPS | $ per share | not reported | [1.95](/filings/0000081362-25-000059.md) | [1.94](/filings/0000081362-25-000120.md) | [1.81](/filings/0001628280-25-047572.md) | not reported | [0.73](/filings/0001628280-26-028949.md) | [(3.78)](/filings/0001628280-26-051107.md) | [1.75](/filings/0001628280-26-068284.md) | not reported | [1.13](/filings/0001628280-26-028949.md) | [1.55](/filings/0001628280-26-051107.md) | [1.73](/filings/0001628280-26-068284.md) |
| Basic EPS | $ per share | not reported | [1.96](/filings/0000081362-25-000059.md) | [1.94](/filings/0000081362-25-000120.md) | [1.81](/filings/0001628280-25-047572.md) | not reported | [0.73](/filings/0001628280-26-028949.md) | [(3.78)](/filings/0001628280-26-051107.md) | [1.75](/filings/0001628280-26-068284.md) | not reported | [1.13](/filings/0001628280-26-028949.md) | [1.56](/filings/0001628280-26-051107.md) | [1.74](/filings/0001628280-26-068284.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [195](/filings/0000081362-25-000014.md) | [196](/filings/0000081362-24-000058.md) | [189](/filings/0000081362-24-000119.md) | [212](/filings/0000081362-24-000134.md) | [189](/filings/0001628280-26-010694.md) | [186](/filings/0000081362-25-000059.md) | [202](/filings/0000081362-25-000120.md) | [172](/filings/0001628280-25-047572.md) | [180](/filings/0001628280-26-068284.md) | [170](/filings/0001628280-26-028949.md) | [155](/filings/0001628280-26-051107.md) | [167](/filings/0001628280-26-068284.md) |
| Current assets | $m | [928](/filings/0000081362-25-000014.md) | [933](/filings/0000081362-24-000058.md) | [919](/filings/0000081362-24-000119.md) | [942](/filings/0000081362-24-000134.md) | [876](/filings/0001628280-26-010694.md) | [912](/filings/0000081362-25-000059.md) | [974](/filings/0000081362-25-000120.md) | [946](/filings/0001628280-25-047572.md) | [921](/filings/0001628280-26-068284.md) | [953](/filings/0001628280-26-028949.md) | [991](/filings/0001628280-26-051107.md) | [1,049](/filings/0001628280-26-068284.md) |
| Total assets | $m | [2,714](/filings/0000081362-25-000014.md) | [2,714](/filings/0000081362-24-000058.md) | [2,672](/filings/0000081362-24-000119.md) | [2,736](/filings/0000081362-24-000134.md) | [2,611](/filings/0001628280-26-010694.md) | [2,664](/filings/0000081362-25-000059.md) | [2,849](/filings/0000081362-25-000120.md) | [2,817](/filings/0001628280-25-047572.md) | [2,798](/filings/0001628280-26-068284.md) | [2,802](/filings/0001628280-26-028949.md) | [2,851](/filings/0001628280-26-051107.md) | [2,915](/filings/0001628280-26-068284.md) |
| Current liabilities | $m | [368](/filings/0000081362-25-000014.md) | [350](/filings/0000081362-24-000058.md) | [350](/filings/0000081362-24-000119.md) | [371](/filings/0000081362-24-000134.md) | [380](/filings/0001628280-26-010694.md) | [373](/filings/0000081362-25-000059.md) | [380](/filings/0000081362-25-000120.md) | [383](/filings/0001628280-25-047572.md) | [380](/filings/0001628280-26-068284.md) | [388](/filings/0001628280-26-028949.md) | [403](/filings/0001628280-26-051107.md) | [426](/filings/0001628280-26-068284.md) |
| Total liabilities | $m | [1,329](/filings/0000081362-25-000014.md) | [1,323](/filings/0000081362-24-000058.md) | [1,277](/filings/0000081362-24-000119.md) | [1,289](/filings/0000081362-24-000134.md) | [1,256](/filings/0001628280-26-010694.md) | [1,278](/filings/0000081362-25-000059.md) | [1,503](/filings/0000081362-25-000120.md) | [1,450](/filings/0001628280-25-047572.md) | [1,421](/filings/0001628280-26-068284.md) | [1,423](/filings/0001628280-26-028949.md) | [1,471](/filings/0001628280-26-051107.md) | [1,498](/filings/0001628280-26-068284.md) |
| Long-term debt | $m | [731](/filings/0000081362-25-000014.md) | [740](/filings/0000081362-24-000058.md) | [704](/filings/0000081362-24-000119.md) | [701](/filings/0000081362-24-000134.md) | [670](/filings/0001628280-26-010694.md) | [699](/filings/0000081362-25-000059.md) | [898](/filings/0000081362-25-000120.md) | [839](/filings/0001628280-25-047572.md) | [835](/filings/0001628280-26-068284.md) | [837](/filings/0001628280-26-028949.md) | [858](/filings/0001628280-26-051107.md) | [871](/filings/0001628280-26-068284.md) |
| Current portion of debt | $m | [23.4](/filings/0000081362-25-000014.md) | [27.8](/filings/0000081362-24-000058.md) | [32.4](/filings/0000081362-24-000119.md) | [38.8](/filings/0000081362-24-000134.md) | [37.6](/filings/0001628280-26-010694.md) | [37.3](/filings/0000081362-25-000059.md) | [37.9](/filings/0000081362-25-000120.md) | [35.9](/filings/0001628280-25-047572.md) | [35.7](/filings/0001628280-26-068284.md) | [37.3](/filings/0001628280-26-028949.md) | [15.7](/filings/0001628280-26-051107.md) | [20.5](/filings/0001628280-26-068284.md) |
| Short-term borrowings | $m | [23.4](/filings/0000081362-25-000014.md) | [27.8](/filings/0000081362-24-000058.md) | [32.4](/filings/0000081362-24-000119.md) | [38.8](/filings/0000081362-24-000134.md) | [37.6](/filings/0001628280-26-010694.md) | [37.3](/filings/0000081362-25-000059.md) | [37.9](/filings/0000081362-25-000120.md) | [35.9](/filings/0001628280-25-047572.md) | [35.7](/filings/0001628280-26-068284.md) | [37.3](/filings/0001628280-26-028949.md) | [15.7](/filings/0001628280-26-051107.md) | [20.5](/filings/0001628280-26-068284.md) |
| Shareholders' equity | $m | [1,384](/filings/0000081362-25-000014.md) | [1,391](/filings/0000081362-24-000058.md) | [1,395](/filings/0000081362-24-000119.md) | [1,446](/filings/0000081362-24-000134.md) | [1,354](/filings/0001628280-26-010694.md) | [1,386](/filings/0000081362-25-000059.md) | [1,342](/filings/0000081362-25-000120.md) | [1,364](/filings/0001628280-25-047572.md) | [1,373](/filings/0001628280-26-068284.md) | [1,376](/filings/0001628280-26-028949.md) | [1,377](/filings/0001628280-26-051107.md) | [1,414](/filings/0001628280-26-068284.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [79.6 d](/filings/0001628280-26-010694.md) | [27.2](/filings/0000081362-25-000059.md) | [46.3 d](/filings/0000081362-25-000120.md) | [68.0 d](/filings/0001628280-25-047572.md) | [63.1 d](/filings/0001628280-26-010694.md) | [(3.1)](/filings/0001628280-26-028949.md) | [41.6 d](/filings/0001628280-26-051107.md) | [51.4 d](/filings/0001628280-26-068284.md) | [46.5 d](/filings/0001628280-26-010694.md) | [3.8](/filings/0001628280-26-028949.md) | [29.5 d](/filings/0001628280-26-051107.md) | [14.3 d](/filings/0001628280-26-068284.md) |
| Capital expenditure | $m | [13.0 d](/filings/0001628280-26-010694.md) | [4.5](/filings/0000081362-25-000059.md) | [6.7 d](/filings/0000081362-25-000120.md) | [8.2 d](/filings/0001628280-25-047572.md) | [22.5 d](/filings/0001628280-26-010694.md) | [12.3](/filings/0001628280-26-028949.md) | [8.0 d](/filings/0001628280-26-051107.md) | [13.3 d](/filings/0001628280-26-068284.md) | [22.2 d](/filings/0001628280-26-010694.md) | [10.7](/filings/0001628280-26-028949.md) | [10.4 d](/filings/0001628280-26-051107.md) | [11.4 d](/filings/0001628280-26-068284.md) |
| Dividends paid | $m | [8.2 d](/filings/0001628280-26-010694.md) | [8.2](/filings/0000081362-25-000059.md) | [8.2 d](/filings/0000081362-25-000120.md) | [8.2 d](/filings/0001628280-25-047572.md) | [8.6 d](/filings/0001628280-26-010694.md) | [8.6](/filings/0001628280-26-028949.md) | [8.6 d](/filings/0001628280-26-051107.md) | [8.4 d](/filings/0001628280-26-068284.md) | [8.8 d](/filings/0001628280-26-010694.md) | [8.8](/filings/0001628280-26-028949.md) | [8.8 d](/filings/0001628280-26-051107.md) | [8.7 d](/filings/0001628280-26-068284.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-26-010694.md) | not reported | not reported | [15.1 d](/filings/0001628280-25-047572.md) | [26.3 d](/filings/0001628280-26-010694.md) | not reported | not reported | [3.8 d](/filings/0001628280-26-068284.md) | [5.0 d](/filings/0001628280-26-010694.md) | not reported | not reported | [3.3 d](/filings/0001628280-26-068284.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.9](/filings/0000081362-24-000058.md) | [17.9](/filings/0000081362-24-000119.md) | [17.9](/filings/0000081362-24-000134.md) | [17.9](/filings/0000081362-25-000059.md) | [17.9](/filings/0000081362-25-000120.md) | [17.9](/filings/0001628280-25-047572.md) | [17.7](/filings/0001628280-26-028949.md) | [17.6](/filings/0001628280-26-051107.md) | [17.4](/filings/0001628280-26-068284.md) | [17.4](/filings/0001628280-26-028949.md) | [17.2](/filings/0001628280-26-051107.md) | [17.3](/filings/0001628280-26-068284.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,191,961 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068284.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 19:09 ET. No prices; not investment advice.